Compare CJET & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CJET | ACON |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | CJET | ACON |
|---|---|---|
| Price | $0.87 | $6.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 3.0M | 61.7K |
| Earning Date | 03-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,107,000.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.82 | $5.55 |
| 52 Week High | $299.00 | $3,499.49 |
| Indicator | CJET | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 48.03 |
| Support Level | $0.82 | $5.71 |
| Resistance Level | $1.28 | $6.89 |
| Average True Range (ATR) | 0.29 | 0.61 |
| MACD | -0.14 | 0.06 |
| Stochastic Oscillator | 2.07 | 35.04 |
Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.